Institutional Ownership Corcept Therapeutics Inc (CORT)
This table provides information about the institutional ownership of Corcept Therapeutics Inc (CORT). We have compiled data on the 416 institutions that hold shares in the stock, with a total of 84.2 Million shares, which have been reported (via 13F filing form) to have a value of $5.45 Billion.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
16,539,159
shares
|
$1.19 Billion
0.01% of portfolio
|
Q2 2024
Reduced 1.71%
|
|
|
Vanguard Group Inc
Valley Forge, PA |
Feb 11, 2025 Q4 2024 |
10,115,624
shares
|
$726 Million
0.01% of portfolio
|
Q4 2024
Added 1.09%
|
|
|
Ingalls & Snyder LLC
New York, NY |
Jan 29, 2025 Q4 2024 |
8,099,747
shares
|
$581 Million
16.01% of portfolio
|
Q4 2024
Reduced 2.02%
|
|
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
Feb 13, 2025 Q4 2024 |
6,198,602
shares
|
$445 Million
0.49% of portfolio
|
Q4 2024
Reduced 4.77%
|
|
|
Parallel Advisors, LLC
|
Apr 07, 2025 Q1 2025 |
3,972,416
shares
|
$285 Million
5.04% of portfolio
|
Q1 2025
Added 3.73%
|
|
|
State Street Corp
Boston, MA |
Feb 14, 2025 Q4 2024 |
3,548,352
shares
|
$255 Million
0.01% of portfolio
|
Q4 2024
Added 0.83%
|
|
|
Dimensional Fund Advisors LP
Austin, TX |
Feb 13, 2025 Q4 2024 |
2,078,568
shares
|
$149 Million
0.03% of portfolio
|
Q4 2024
Reduced 17.92%
|
|
|
Geode Capital Management, LLC
Boston, MA |
Feb 12, 2025 Q4 2024 |
2,068,175
shares
|
$148 Million
0.01% of portfolio
|
Q4 2024
Reduced 13.06%
|
|
|
Arrowstreet Capital, Limited Partnership
Boston, MA |
Feb 12, 2025 Q4 2024 |
1,644,942
shares
|
$118 Million
0.07% of portfolio
|
Q4 2024
Added 4.07%
|
|
|
Jacobs Levy Equity Management, Inc
Florham Park, NJ |
Feb 14, 2025 Q4 2024 |
1,376,881
shares
|
$98.8 Million
0.27% of portfolio
|
Q4 2024
Added 12.51%
|
|
|
Morgan Stanley
New York, NY |
Feb 14, 2025 Q4 2024 |
1,261,379
shares
|
$90.6 Million
0.0% of portfolio
|
Q4 2024
Reduced 13.52%
|
|
|
First Trust Advisors LP
Wheaton, IL |
Feb 13, 2025 Q4 2024 |
1,064,122
shares
|
$76.4 Million
0.05% of portfolio
|
Q4 2024
Reduced 19.27%
|
|
|
Charles Schwab Investment Management Inc
San Francisco, CA |
Feb 06, 2025 Q4 2024 |
1,051,560
shares
|
$75.5 Million
0.01% of portfolio
|
Q4 2024
Added 2.44%
|
|
|
Northern Trust Corp
Chicago, IL |
Feb 14, 2025 Q4 2024 |
1,015,515
shares
|
$72.9 Million
0.01% of portfolio
|
Q4 2024
Added 10.22%
|
|
|
D. E. Shaw & Co., Inc.
New York, NY |
Feb 14, 2025 Q4 2024 |
886,576
shares
|
$63.6 Million
0.04% of portfolio
|
Q4 2024
Added 12.5%
|
|
|
Norges Bank
Oslo, Q8 |
Feb 12, 2025 Q4 2024 |
834,591
shares
|
$59.9 Million
0.01% of portfolio
|
Q4 2024
New holding
|
|
|
Connor, Clark & Lunn Investment Management Ltd.
|
Feb 10, 2025 Q4 2024 |
796,795
shares
|
$57.2 Million
0.2% of portfolio
|
Q4 2024
Reduced 7.3%
|
|
|
Invesco Ltd.
Atlanta, GA |
Feb 13, 2025 Q4 2024 |
706,133
shares
|
$50.7 Million
0.01% of portfolio
|
Q4 2024
Reduced 17.64%
|
|
|
Goldman Sachs Group Inc
New York, NY |
Feb 11, 2025 Q4 2024 |
626,246
shares
|
$45 Million
0.01% of portfolio
|
Q4 2024
Added 32.39%
|
|
|
Cerity Partners LLC
New York, NY |
Feb 13, 2025 Q4 2024 |
607,946
shares
|
$43.6 Million
0.07% of portfolio
|
Q4 2024
Reduced 0.63%
|
|
|
Boston Trust Walden Corp
|
Apr 21, 2025 Q1 2025 |
584,800
shares
|
$42 Million
0.5% of portfolio
|
Q1 2025
Reduced 34.95%
|
|
|
Principal Financial Group Inc
Des Moines, IA |
Jan 31, 2025 Q4 2024 |
517,332
shares
|
$37.1 Million
0.02% of portfolio
|
Q4 2024
New holding
|
|
|
Aj Wealth Strategies, LLC
|
Jul 20, 2023 Q2 2023 |
509,934
shares
|
$36.6 Million
0.55% of portfolio
|
Q2 2022
Added 28.76%
|
|
|
Israel Englander
Millennium Management LLC | New York, Ny
|
Feb 14, 2025 Q4 2024 |
508,357
shares
|
$36.5 Million
0.01% of portfolio
|
Q4 2024
Added 112.5%
|
|
|
Clearbridge Investments, LLC
New York, NY |
Feb 12, 2025 Q4 2024 |
481,389
shares
|
$34.6 Million
0.02% of portfolio
|
Q4 2024
Reduced 9.8%
|